Ayyagari A, Khanna T, Devi S
Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research Chandigarh.
Indian J Med Res. 1992 Jan;95:34-40.
Antibodies for B. fragilis (NCTC 9343) were detected in sera of 121 patients and 37 controls using four methods viz., enzyme linked immunosorbent assay (ELISA), indirect fluorescence test (JFA), countercurrent immunoelectrophoresis (CIE) and indirect haemagglutination test (IHA). Of 121 patients, 57 were culture positive for B. fragilis, 38 positive for anaerobes other than B. fragilis and 26 were negative for anaerobes. In the B. fragilis culture positive group, antibodies to B. fragilis were positive in 82.5, 84.2, 85.90 and 91.2 per cent patients by CIE, ELISA, IHA and IFA respectively. In B. fragilis positive patients IFA was more sensitive than IHA, which for other groups IHA was found to be more sensitive than IFA. When all groups were taken together IHA was found more sensitive than IFA. ELISA and IFA tests are recommended for rapid serological diagnosis of B. fragilis infections, where facilities for these tests are not available, CIE and IHA could be done. Cross reactivity with other Gram negative anaerobic and aerobic bacteria should be kept in mind since seropositivity varied for B. fragilis (82-91%). In infections with microbes other than B. fragilis seropositivity varied between 23.7 to 63.2 per cent and in patients having cultures sterile or positive for other organisms seropositivity was 30.8 to 42.3 per cent. This nonspecificity could be due to other antigens that cross react between B. fragilis and other anaerobes and aerobes or the use of an antigen lacking high purity.
采用酶联免疫吸附测定(ELISA)、间接荧光试验(IFA)、对流免疫电泳(CIE)和间接血凝试验(IHA)这四种方法,在121例患者和37例对照者的血清中检测脆弱拟杆菌(NCTC 9343)抗体。121例患者中,57例脆弱拟杆菌培养阳性,38例除脆弱拟杆菌外的厌氧菌培养阳性,26例厌氧菌培养阴性。在脆弱拟杆菌培养阳性组中,通过CIE、ELISA、IHA和IFA检测,分别有82.5%、84.2%、85.90%和91.2%的患者脆弱拟杆菌抗体呈阳性。在脆弱拟杆菌阳性患者中,IFA比IHA更敏感,而在其他组中,IHA比IFA更敏感。当将所有组合并在一起时,发现IHA比IFA更敏感。推荐使用ELISA和IFA进行脆弱拟杆菌感染的快速血清学诊断;如果没有这些检测的设备,也可以进行CIE和IHA检测。由于脆弱拟杆菌的血清阳性率在82%至91%之间变化,应牢记与其他革兰氏阴性厌氧菌和需氧菌的交叉反应。在非脆弱拟杆菌微生物感染中,血清阳性率在23.7%至63.2%之间变化,在培养无菌或其他生物体培养阳性的患者中,血清阳性率为30.8%至42.3%。这种非特异性可能是由于脆弱拟杆菌与其他厌氧菌和需氧菌之间交叉反应的其他抗原,或者是使用了纯度不高的抗原。